Study on the interaction between remimazolam and inhaled anesthetics (sevoflurane)

Kobayashi Kensuke0 个研究点目标入组 100 人开始时间: 2023年11月10日最近更新: 2024年1月22日

试验速览

暂无简介。

•1. patients who are between 40 and 60 years of age at the time of consent
•2. patients scheduled for i-gel insertion for non-emergency (scheduled or temporary) surgery
•3. patients with ASA (American Society of Anesthesiologists) Class I or II status
•4. patients who have given their consent to this study by signing the consent form

•1. those who are expected to have difficulty in intubation (e.g., with impaired opening, Mallampati Grade III or IV, etc.) 2.
•2. patients undergoing surgery requiring intubation
•3. patients with symptoms of airway infection 4. benzodiazepines or benzodiazepines
•4. patients with a history of hypersensitivity to benzodiazepines or flumazenil
•5. patients who should avoid sevoflurane (e.g., history of malignant hyperthermia or family history of malignant hyperthermia)
•6. patients with a history of hypersensitivity to rocuronium
•7. severely obese (BMI > 35)
•Pregnant patients
•9. nursing mothers and postpartum mothers
•10. patients with the possibility of aspiration
•11.Patients with a history of hypersensitivity to remimazolam
•12.Patients with a history of glaucoma
•13.Patients who regularly use benzodiazepines
•14.Persons with psychiatric disorders
•15. other patients who are judged to be exempted by the principal investigator/associate investigator

发起方

Kobayashi Kensuke